Togo

Reimbursed Care Access

Togo maintains a restrictive legal framework toward narcotics and psychotropic plants/compounds: possession, cultivation, trafficking and non-authorised use of substances classified as narcotics or psychotropic are prohibited under the national penal code, while ketamine is retained as an essential anesthetic in the national medicines list and is used in medical settings. There is no public evidence of national approvals, reimbursement pathways, or regulated therapeutic programs for classic psychedelic compounds (psilocybin, MDMA, DMT family, ibogaine, mescaline, 2C-X, ayahuasca) outside of regulated research or strict criminal-prohibition contexts. [https://www.unodc.org/cld/en/legislation/tgo/code_penal/titre_ii_-_chapitre_v/articles_248_253-258_260-267_269-270/articles_248_253-258_260-267_269-270.html|UNODC - Togo Penal Code] [https://www.who.int/publications/m/item/togo--liste-nationale-des-m-dicaments-essentiels-sous-dci-pour-les-adultes-2021-%28french%29|WHO - Togo National List of Essential Medicines (2021)].